Richard Blaylock

Partner

Pillsbury Winthrop Shaw Pittman LLP

Richard Blaylock

Partner

Pillsbury Winthrop Shaw Pittman LLP

Richard Blaylock’s practice covers financing, M&A, licensing, collaboration and partnering arrangements, and intellectual property counseling for start-up and established companies whose value derives from innovative technology.

Richard is well-versed in a wide array of technologies, including those germane to both life sciences (pharmaceuticals, biologics, and diagnostics) as well as high technology (software, robotics, wireless, novel materials, and pollution control). He has counseled companies across a wide range of technologies with respect to company formation, licensing, partnering and collaborations, financing and intellectual property strategy, as well as patent, license, trademark, trade secrets and unfair competition disputes.

A person listed as a contributor has spoken or otherwise participated in Regulatory Transparency Project events, publications, or multimedia presentations. A person's appearance on the website does not imply an endorsement or relationship between the person and the Regulatory Transparency Project. The Regulatory Transparency Project takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.

Contributions

Deep Dive Episode 177 – Patents and Pandemics: Innovation Policy and the Patent Waiver Petition at the WTO

May 6, 2021

Experts debate the role of patents in medical care and how the US should respond to the petition submitted to the WTO to waive all intellectual property rights on drugs, vaccines, or other responses to the COVID-19 pandemic.

Listen to this podcast
Skip to content